Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
22.97
-0.30 (-1.29%)
Mar 26, 2026, 11:30 AM CST
SHA:600332 Market Cap
SHA:600332 has a market cap or net worth of 36.05 billion as of March 25, 2026. Its market cap has decreased by -12.15% in one year.
Market Cap
36.05B
Enterprise Value
30.15B
Revenue
77.66B
Ranking
n/a
PE Ratio
12.68
Stock Price
22.97
Market Cap Chart
Since February 6, 2001, SHA:600332's market cap has increased from 3.73B to 36.05B, an increase of 866.94%. That is a compound annual growth rate of 9.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 36.05B | -9.18% |
| Dec 31, 2025 | 39.69B | -9.21% |
| Dec 31, 2024 | 43.72B | -1.87% |
| Dec 29, 2023 | 44.55B | -3.89% |
| Dec 30, 2022 | 46.36B | -11.03% |
| Dec 31, 2021 | 52.10B | 16.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Pharmaceuticals Holding | 54.96B |
| Jointown Pharmaceutical Group | 24.98B |
| China National Medicines Corporation | 21.60B |
| Liaoning Cheng Da | 16.82B |
| China Meheco Group | 14.96B |
| China National Accord Medicines Corporation | 13.06B |
| Qingdao Baheal Medical INC. | 11.04B |
| C.Q. Pharmaceutical Holding | 9.45B |